HER2+ Metastatic Colorectal Cancer: Clinical Trial Data With

Focused discussion on clinical trial data with trastuzumab deruxtecan in the setting of HER2+ metastatic colorectal cancer.

Related Keywords

, Evolving Testing , Treatment Strategies , Metastatic Colorectal Cancer , Clinical Trial Data With , Colorectal Cancer , Crc , Dmcrc , Her2 Positive , Ther2 , Her2 Crc , Her2 Antibodies , Btrastuzumab , Trastuzumab Deruxtecan , Tdxd , T Dxd , Destiny Crc01 , Dose Adjustment , Dose Reduction , Ild , Interstitial Lung Disease , Asco 2023 , Asco Annual Meeting ,